基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He sits on several foundations, NIH and Department of Defense peer review panels and sits on several Editorial boards. He has consulted for many companies including Lilly, Parke-Davis, Pfizer, Centocor, Immunex, Amgen, Novartis, Merck and Eisai Pharmaceuticals. Key research accomplishments include (1) defining importance of osteoclastic activity and targeting it in prostate cancer leading to clinical use of RANKL inhibitor (Denosumab); (2) identification of raf kinase inhibitor protein (RKIP) as a novel metastasis suppressor gene; (3) determining the importance of the Wnt pathway in bone metastasis; and (4) defining interleukin-6 as a contributor to castration resistant prostate cancer.
Research Interests
Papers共 463 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Matthew D. Wainstein,Jake McGue,Tyler Robinson,Rohit Mehra,Simpa S. Salami,Tim Frankel,Aaron Udager,Evan T. Keller,Allison M. May, Jonathan Jiang
Urologic Oncology: Seminars and Original Investigations (2024)
Allison M. May,Claire Williams, Shaye Hagler, Michael McNiff,Tyler Robinson,Simpa Salami,Aaron Udager,Evan T. Keller
Allison M. May, Matthew Wainstein,Jake McGue,Tyler Robinson,Rohit Mehra,Simpa S. Salami,Tim Frankel,Aaron Udager,Evan T. Keller
CANCER RESEARCHno. 11 (2023): A067-A067
Lingxin Zhu, Yi Tang, Xiao-Yan Li,Samuel A. Kerk,Costas A. Lyssiotis, Wenqing Feng,Xiaoyue Sun,Geoffrey E. Hespe, Zijun Wang,Marc P. Stemmler,Simone Brabletz,Thomas Brabletz,
EMBO JOURNALno. 7 (2023)
The Journal of Urologyno. Supplement 4 (2023): E500-E501
CANCER RESEARCHno. 16 (2023): PR014-PR014
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn